Direct correction of haemoglobin E β-thalassaemia using base editors.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37604-8
- By:
- Publication type:
- Article
Works by Yasara, Nirmani
Results: 6
1
2
Synergistic silencing of α-globin and induction of γ-globin by histone deacetylase inhibitor, vorinostat as a potential therapy for β-thalassaemia.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-48204-2
- By:
- Publication type:
- Article
3
Electronic screen device usage and screen time among preschool-attending children in a suburban area of Sri Lanka.
- Published in:
- 2022
- By:
- Publication type:
- journal article
4
A randomised double-blind placebo-controlled clinical trial of oral hydroxyurea for transfusion-dependent β-thalassaemia.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-06774-8
- By:
- Publication type:
- Article
5
Association of GDF15 levels with body mass index and endocrine status in β‐thalassaemia.
- Published in:
- Clinical Endocrinology, 2023, v. 99, n. 2, p. 182, doi. 10.1111/cen.14897
- By:
- Publication type:
- Article
6
A comprehensive review of hydroxyurea for β-haemoglobinopathies: the role revisited during COVID-19 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- journal article